MBIO:NASDAQ
Mustang Bio Inc
US$Â 0.40
arrow_upward
+0.47%(+0.0019) Siku 1
12 Okt, 14:49:30 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya MBIO...
Fungua
US$Â 0.41
Juu
US$Â 0.44
Chini
US$Â 0.38
Mtaji wa soko
3.05M
Wastani wa kiasi cha mauzo
elfu 31.29
Kiasi cha mauzo ya hisa
elfu 37.51
Juu kwa wiki 52
US$Â 1.69
Chini kwa wiki 52
US$Â 0.38
EPS
-US$Â 0.46
Beta
2.09
Hisa za wawekezaji
6.73M
Idadi ya wafanyakazi
4
Fungua
US$Â 0.41
Juu
US$Â 0.44
Chini
US$Â 0.38
Mtaji wa soko
3.05M
Wastani wa kiasi cha mauzo
elfu 31.29
Kiasi cha mauzo ya hisa
elfu 37.51
Juu kwa wiki 52
US$Â 1.69
Chini kwa wiki 52
US$Â 0.38
EPS
-US$Â 0.46
Beta
2.09
Hisa za wawekezaji
6.73M
Idadi ya wafanyakazi
4
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
https://www.dars.gov.et/
·
wiki 1 iliyopita
MBIO Q4 2024 Earnings: Wider-Than-Expected Loss Per Share Dominates the Quarter - Profit Margin Analysis
Wasifu
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Kuhusu Mustang Bio Inc
Afisa Mkuu Mtendaji (CEO)Manuel Litchman
Wafanyakazi4
Lilianzishwa2015
Makao makuuWaltham, Massachusetts, Marekani
Sekta-
Tovutimustangbio.com